• Shares of Bruker Corporation (NASDAQ:BRKR) traded higher on Wednesday after Frank Laukien, the chief executive officer of the life sciences firm, purchased over $5M worth of company stock.
• More than 1.6 million shares of Bruker (NASDAQ:BRKR) have changed hands compared to the 65-day average of ~1.2 million as the stock added ~5%, which, if the gain holds, would mark BRKR's best intraday advance in over five years.
• According to an SEC filing on Tuesday, Laukien, who has served as Bruker’s (BRKR) CEO for over thirty years, bought 100K company shares in three transactions.
• His purchases, made at prices ranging from $49.82 to $51.36 on average, were worth more than $5.0M in total.
• Following the transactions conducted on Monday, Laukien, the biggest shareholder of Bruker (BRKR), has increased his direct ownership of company shares to ~38.4 million.

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。